Occam Recruits Kim Blackwell to Board of NVIDIA-Backed Charm Therapeutics
In September 2025, Occam Global recruited Kim Blackwell, MD, to the Board of CHARM Therapeutics.
Kim was most recently CEO of Zentalis Pharmaceuticals, a public, clinical-stage oncology company, and previously served as Chief Medical Officer at Tempus. She joins the board as a non-executive director, bringing extensive oncology and clinical development experience, which will be crucial for the advancement of CHARM’s clinical program.
Kim earned a Bachelor's degree in Bioethics/Medical Ethics from Duke University and her MD from the Mayo Clinic Alix School of Medicine.
Occam Global is an international life science executive search and leadership advisory firm dedicated to building management teams for innovative companies in the biotech, techbio, life sciences, and venture capital sectors. Our firm’s unique strength lies in our seamless access to elite talent, proven expertise in aligning exceptional business and scientific leaders with optimal opportunities, and a steadfast dedication to creating meaningful industry impact, guided by elevated ethics and enlightened aggression. Trusted by entrepreneurs, investors, and corporations worldwide, Occam Global is recognized as the premier partner for executive search and recruitment in the life sciences. Our success is rooted in establishing trust, cultivating and valuing relationships, and committing to serve as forthright and good-humored partners in realizing extraordinary ambitions.